Concepedia

Victoria Neiman

VN

Statistics

Publications

23

Citations

6.5K

H-Index

19

Active since

2009

Affiliations

Rabin Medical Center(Current)

Tel Aviv University

Rambam Health Care Campus

Sheba Medical Center

Tel Aviv Sourasky Medical Center

Victoria Neiman is an author at Rabin Medical Center specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2009–2024

23

Publications

23

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera et al. · New England Journal of Medicine · 2018 · 4.6K citations · Full text

, , +11

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Robert J. Motzer, Brian I. Rini, David F. McDermott et al. · The Lancet Oncology · 2019 · 780 citations · Full text

, , +12

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

Robert J. Motzer, Bernard Escudier, David F. McDermott et al. · Journal for ImmunoTherapy of Cancer · 2020 · 225 citations · Full text

, , +16

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

, , +11

CheckMate 214: Efficacy and safety of nivolumab + ipilimumab (N+I) v sunitinib (S) for treatment-naïve advanced or metastatic renal cell carcinoma (mRCC), including IMDC risk and PD-L1 expression subgroups

Bernard Escudier, Nizar M. Tannir, David F. McDermott et al. · Annals of Oncology · 2017 · 88 citations

, , +13

1–5 of 23